Transfer of trimethoprim resistance from fecal Escherichia coli isolated during a prophylaxis study in Mexico
- PMID: 6341477
- DOI: 10.1093/infdis/147.4.724
Transfer of trimethoprim resistance from fecal Escherichia coli isolated during a prophylaxis study in Mexico
Abstract
Forty-one of 100 trimethoprim-resistant fecal isolates of Escherichia coli isolated during a diarrhea prophylaxis study transferred trimethoprim resistance to an E. coli K12 derivative at frequencies ranging from 1 x 10(-7) to 2 x 10(-2). Analysis of these transconjugants, after attempting to select those that had received only one plasmid, revealed that 34 (83%) were resistant to trimethoprim plus only one or two of seven other antimicrobial agents tested, most often ampicillin and/or streptomycin. In contrast, 91% of the donor strains were resistant to four or more antimicrobial agents. Plasmid analysis demonstrated that a 35-megadalton plasmid was present in 35 transconjugants and was usually associated with resistance to trimethoprim, streptomycin, and ampicillin; 19 transconjugants had only a 35-megadalton plasmid and were resistant to only these three antimicrobial agents, raising the possibility that a common plasmid was present in many strains. Although resistance to multiple antimicrobial agents could be transferred to the K12 recipient, resistance to more than three agents was seldom mediated by a single plasmid. The high degree of transferability of trimethoprim resistance from these fecal isolates of E. coli emphasizes the potential for the dissemination of genes carrying trimethoprim resistance.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
